Ms. Tran Bao Lam – General Director of GIGAMED and Mr. Christos Gallis – Vice President of STADA Group, officially signed the Strategic Partnership Agreement in Vietnam.
(PLVN) – As of February 2023, STADA Pymepharco and GIGAMED officially entered into a strategic partnership for the Consumer Healthcare product portfolio in Vietnam‘s retail market.
With this agreement, GIGAMED has officially become STADA Pymepharco’s strategic partner for the development and distribution of Consumer Healthcare products in Vietnam.
STADA Pymepharco is a member of the STADA Group – a multinational pharmaceutical company headquartered in Germany with a legacy spanning over 125 years. With a diverse product portfolio including Prescription medicines, Consumer Healthcare, and Specialty, STADA currently ranks as the fourth in pharmaceutical sales across Europe. In Vietnam, STADA Pymepharco operates in both Prescription and Consumer Healthcare sedgment.
Recognizing the strong growth potential of the Consumer Healthcare sector in Vietnam, STADA Pymepharco has continuously sought out strategic partners to drive the expansion in its non-prescription medicines, functional supplements, and cosmetics portfolio. After a comprehensive evaluation process based on various criteria, GIGAMED has officially been selected as the company’s strategic partner to fulfill this mission in Vietnam.
With a robust nationwide distribution network, modern infrastructure, and extensive industry expertise, GIGAMED has consistently invested in development to become one of Vietnam’s leading pharmaceutical companies. Grounded in strong core values that emphasize responsibility, integrity, and sustainability, GIGAMED is currently the trusted distribution partner for several top global pharmaceutical brands in the Vietnamese market.
The strategic partnership between STADA Pymepharco and GIGAMED marks a significant advancement in market access strategies, coverage management, and delivered added values for consumer. Under this agreement, GIGAMED will act as the exclusive distributor and sales partner for the retail market – including independent pharmacies, pharmacy chains, and other healthcare service providers.
“Our partnership with GIGAMED will enable STADA to capture new opportunities and accelerate the growth of our Consumer Healthcare business in Vietnam’s retail market – which is one of our Group’s top strategic priorities”, shared Mr. Christos Gallis, Vice President of STADA Group.
“Becoming STADA Pymepharco’s strategic partner for non-prescription medicines, vitamin & food supplements, and cosmetics in Vietnam is a strong testament to GIGAMED’s capability and value. We are proud to bring high-quality healthcare products to Vietnamese consumers and contribute to a healthier future for millions”, said Ms. Tran Bao Lam, General Director of GIGAMED.
According to Ngoc Anh
Source: Vietnam Law News (Báo Pháp luật)
